window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 13, 2026

  • News
  • About Us
Contact Us

EcoVadis

  • CDMOs & Manufacturing,Global health,Regulatory Affairs,Research & Development,Supply Chain & Logistics,Technology and platforms

    SGD Pharma targets 42% emissions cut by 2030 in new sustainability report

    Company aligns with CSRD and reports top 1% EcoVadis ranking [...]

    July 28, 2025
  • CDMOs & Manufacturing

    Symbiosis earns recognition from EcoVadis for commitment to sustainability

    April 24, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Breast cancer tops list of most-studied diseases for fifth consecutive year, Phesi analysis finds
    Categories: Artificial Intelligence, Clinical Development, Clinical Trials, Data Management, Oncology, Research & Development
  • TECregen raises CHF 10m (EUR 10.7m) seed financing and appoints Dr Bo Rode Hansen as chairman
    Categories: Biologics & Biosimilars, Biotech, Immunology, Partnerships & Funding, Research & Development
  • Pharmapack 2026 to return to Paris with focus on GLP-1 therapies and sustainable packaging
    Categories: Drug Delivery & Formulation, Events and Conferences, Manufacturing, Packaging, Sustainability
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top